| Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events DL Bhatt, KAA Fox, W Hacke, PB Berger, HR Black, WE Boden, P Cacoub, ... New England Journal of Medicine 354 (16), 1706-1717, 2006 | 3882 | 2006 |
| Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial SR Steinhubl, PB Berger, JT Mann III, ETA Fry, A DeLago, C Wilmer, ... Jama 288 (19), 2411-2420, 2002 | 3692 | 2002 |
| ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary: a report of the American College of Cardiology/American Heart … KA Eagle, PB Berger, H Calkins, BR Chaitman, GA Ewy, KE Fleischmann, ... Journal of the American College of Cardiology 39 (3), 542-553, 2002 | 3172* | 2002 |
| Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention CS Rihal, SC Textor, DE Grill, PB Berger, HH Ting, PJ Best, M Singh, ... circulation 105 (19), 2259-2264, 2002 | 2583 | 2002 |
| Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and … LJ Shaw, DS Berman, DJ Maron, GBJ Mancini, SW Hayes, PM Hartigan, ... Circulation 117 (10), 1283-1291, 2008 | 1965 | 2008 |
| Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial MJ Price, PB Berger, PS Teirstein, JF Tanguay, DJ Angiolillo, D Spriggs, ... Jama 305 (11), 1097-1105, 2011 | 1618 | 2011 |
| ACC/AHA/NHLBI clinical advisory on the use and safety of statins Writing Committee Members:, RC Pasternak, SC Smith Jr, ... Circulation 106 (8), 1024-1028, 2002 | 1611 | 2002 |
| Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans Journal of British Surgery 107 (11), 1440-1449, 2020 | 1497 | 2020 |
| Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis SG Chu, RC Becker, PB Berger, DL Bhatt, JW Eikelboom, B Konkle, ... Journal of Thrombosis and Haemostasis 8 (1), 148-156, 2010 | 1429 | 2010 |
| The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines JD Douketis, PB Berger, AS Dunn, AK Jaffer, AC Spyropoulos, RC Becker, ... Chest 133 (6), 299S-339S, 2008 | 1193 | 2008 |
| Variability in platelet responsiveness to clopidogrel among 544 individuals VL Serebruany, SR Steinhubl, PB Berger, AI Malinin, DL Bhatt, EJ Topol Journal of the American College of Cardiology 45 (2), 246-251, 2005 | 1097 | 2005 |
| Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial DL Bhatt, MD Flather, W Hacke, PB Berger, HR Black, WE Boden, ... Journal of the American College of Cardiology 49 (19), 1982-1988, 2007 | 1027 | 2007 |
| Oxidized phospholipids, Lp (a) lipoprotein, and coronary artery disease S Tsimikas, ES Brilakis, ER Miller, JP McConnell, RJ Lennon, ... New England Journal of Medicine 353 (1), 46-57, 2005 | 968 | 2005 |
| The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions PJM Best, R Lennon, HH Ting, MR Bell, CS Rihal, DR Holmes, PB Berger Journal of the American College of Cardiology 39 (7), 1113-1119, 2002 | 929 | 2002 |
| Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial A Kastrati, J Mehilli, FJ Neumann, F Dotzer, J Ten Berg, H Bollwein, I Graf, ... Jama 295 (13), 1531-1538, 2006 | 816 | 2006 |
| Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of … PB Berger, SG Ellis, DR Holmes Jr, CB Granger, DA Criger, A Betriu, ... Circulation 100 (1), 14-20, 1999 | 782 | 1999 |
| Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. E Deutsch, M Berger, WG Kussmaul, JW Hirshfeld Jr, HC Herrmann, ... Circulation 82 (6), 2044-2051, 1990 | 781 | 1990 |
| Utilization of early invasive management strategies for high-risk patients with non–ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement … DL Bhatt, MT Roe, ED Peterson, Y Li, AY Chen, RA Harrington, ... Jama 292 (17), 2096-2104, 2004 | 716 | 2004 |
| Socialinis tikrovės konstravimas P Berger Problemos 31, 117-130, 1984 | 701 | 1984 |
| Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study R Mehran, U Baber, PG Steg, C Ariti, G Weisz, B Witzenbichler, TD Henry, ... The Lancet 382 (9906), 1714-1722, 2013 | 677 | 2013 |
